Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:PR
NYSE:PROil and Gas

Did Fresh Bullish Coverage on Post-Merger Execution Just Shift Permian Resources' (PR) Investment Narrative?

In recent days, several Wall Street firms, including KeyBanc and Truist Securities, have initiated or reaffirmed positive coverage on Permian Resources, emphasizing its execution since the 2022 Centennial-Colgate merger and its focus on oil and natural gas development in the Permian Basin. This wave of analyst attention highlights growing institutional interest in the company’s operational progress and acquisition-driven model, potentially influencing how investors view its long-term growth...
TSX:H
TSX:HElectric Utilities

Will Denied Recovery of CA$223 Million Storm Costs Change Hydro One's (TSX:H) Narrative?

Hydro One Networks Inc. recently received an Ontario Energy Board decision denying its request to recover about CA$223 million of costs from the March 2025 ice storm under its 2026 Annual Update and Z-factor applications. This setback highlights the limits of regulatory cost recovery for extreme weather events, raising fresh questions about how Hydro One balances resilience investments with earnings protection. We’ll now examine how the denied CA$223 million storm cost recovery shapes Hydro...
TSE:9302
TSE:9302Logistics

A Look At MITSUI-SOKO HOLDINGS (TSE:9302) Valuation After Completing Its Share Buyback Program

MITSUI-SOKO HOLDINGS (TSE:9302) has completed its previously announced share buyback, repurchasing 3,285,600 shares, or 4.39% of outstanding stock, for ¥11,957.61 million, a move that directly affects existing shareholders. See our latest analysis for MITSUI-SOKO HOLDINGS. The buyback comes at a time when momentum in the shares has been strong, with a 15.90% 1 month share price return and a 56.67% 1 year total shareholder return, alongside a very large 5 year total shareholder return. If this...
TSX:HSLV
TSX:HSLVMetals and Mining

Is Corani’s Revival And Staged Build‑Out Altering The Investment Case For Highlander Silver (TSX:HSLV)?

Highlander Silver Corp. recently reported a fifteen‑month net loss of C$16.97 million but, following its combination with Bear Creek Mining, has begun the first exploration drilling in over a decade at the fully permitted Corani silver project in Peru alongside extensive site preparation and infrastructure work. An interesting angle is the company’s plan to complete an updated feasibility study by late Q3 2026 using a staged-development approach aimed at balancing returns per share with...
SEHK:2356
SEHK:2356Banks

Assessing Dah Sing Banking Group (SEHK:2356) Valuation After Strong Results And Higher Final Dividend Proposal

Earnings and dividend announcement set the tone Dah Sing Banking Group (SEHK:2356) has attracted fresh attention after reporting full year 2025 results and proposing an ordinary final dividend of HK$0.49 per share, subject to shareholder approval in June 2026. See our latest analysis for Dah Sing Banking Group. The dividend and earnings news comes after a strong run, with Dah Sing Banking Group’s share price returning 6.46% over the past month and 19.96% over 90 days, while its 1-year total...
SEHK:1024
SEHK:1024Interactive Media and Services

Assessing Kuaishou Technology (SEHK:1024) Valuation After Strong 2025 Earnings And Dividend Announcement

Kuaishou Technology (SEHK:1024) shares moved after the company reported quarterly and full year 2025 earnings, together with a recommended final dividend, giving investors fresh data on cash generation, shareholder returns and recent business performance. See our latest analysis for Kuaishou Technology. The latest 4.01% 1 day share price return, to HK$46.7, comes after a tougher few months, with a 30 day share price return of 22.87% decline and a 90 day share price return of 35.05% decline...
NYSE:LEN
NYSE:LENConsumer Durables

A Look At Lennar (LEN) Valuation After Weak Guidance Earnings Miss And Land Banking Scrutiny

Why Lennar’s recent guidance and land deal are in focus Lennar (LEN) is under close watch after weaker than expected fiscal first quarter guidance, an earnings miss, and fresh questions around its 8.5% land banking arrangement with Millrose Properties pressured the shares. See our latest analysis for Lennar. Lennar’s weaker fiscal first quarter guidance, earnings miss, and land banking scrutiny have coincided with a 15.4% 1 month share price decline and a 15.4% 1 year total shareholder...
NasdaqGS:PLTK
NasdaqGS:PLTKEntertainment

Top Growth Stocks With Strong Insider Confidence

Over the last 7 days, the United States market has risen by 1.2%, contributing to a remarkable 33% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth stocks with high insider ownership often signal strong confidence from those closest to the company, making them worth considering for their potential alignment with current market trends.
NYSE:RSKD
NYSE:RSKDSoftware

Uncovering 3 Penny Stocks With Market Caps Under $700M

The market has climbed 1.2% in the last 7 days and is up 33% over the last 12 months, with earnings forecast to grow by 16% annually. Investing in penny stocks can still open doors to growth opportunities, typically in smaller or newer companies that come backed by strong financial health. Let's explore several penny stocks that could pair balance sheet strength with long-term potential.
NasdaqGS:CCBG
NasdaqGS:CCBGBanks

Undiscovered Gems in the US Market to Explore This April 2026

The United States market has shown impressive momentum, climbing 1.2% in the last week and rising 33% over the past year, with earnings projected to grow by 16% annually. In such a dynamic environment, identifying stocks that offer unique value propositions and growth potential can be key to uncovering hidden opportunities.
NasdaqGS:NBTB
NasdaqGS:NBTBBanks

Top Dividend Stocks Including NBT Bancorp And Two More

The United States market has experienced a 1.2% increase over the last week and a notable 33% rise over the past year, with earnings projected to grow by 16% annually. In this thriving environment, identifying strong dividend stocks can be crucial for investors seeking both income and potential growth, as they offer regular payouts while potentially benefiting from overall market gains.
NasdaqGS:MEDP
NasdaqGS:MEDPLife Sciences

Taking A Fresh Look At Medpace Holdings (MEDP) Valuation After Recent Share Price Rebound

Recent Performance Snapshot Medpace Holdings (MEDP) has attracted attention after recent share price moves, with the stock up about 2.5% over the past day, 5.9% over the past week, and 8.1% over the past month. See our latest analysis for Medpace Holdings. That short term 1 day share price return of 2.5% and 1 month share price return of 8.1% sit against a 90 day share price decline of 17.1% and a 1 year total shareholder return of 83.4%. This suggests momentum has picked up again after a...
NYSE:PNW
NYSE:PNWElectric Utilities

What Pinnacle West Capital (PNW)'s Nuclear Ambitions and Dividend Focus Mean For Shareholders

In recent days, Pinnacle West Capital has gained attention as one of the best utility dividend payers, while also advancing Arizona nuclear license renewal efforts and preparing to report its first-quarter 2026 results in early May after already releasing those figures. This combination of dividend focus and nuclear expansion potential is drawing interest to a company whose underlying operations and financial condition are still viewed as relatively weak and risky. We’ll now examine how...
NYSE:BROS
NYSE:BROSHospitality

Fresh Look At Dutch Bros (BROS) Valuation After New Telsey Outperform Coverage

Analyst coverage sparks fresh look at Dutch Bros Telsey’s new coverage of Dutch Bros (BROS), with a positive view on its loyalty program, comparable sales, and planned store expansion, has put the fast growing drive through coffee chain back on many investors’ radar. See our latest analysis for Dutch Bros. At a share price of US$53.03, Dutch Bros has recently seen a 7 day share price return of 4.68% and a 30 day share price return of 3.35%. Its 90 day share price return of 16.11% and 1 year...
NasdaqGS:LIN
NasdaqGS:LINChemicals

A Look At Linde (LIN) Valuation After New Buy Rating And Expansion-Driven Optimism

Linde (LIN) is back in focus after William O'Neil initiated coverage, highlighting its strong market position, a reported US$10b project backlog, and ties to areas like clean hydrogen and semiconductor manufacturing. See our latest analysis for Linde. The recent 13.92% 90-day share price return and 21.27% 1-year total shareholder return suggest momentum has been building, as investors respond to Linde’s new US facility plans and the announcement of first quarter 2026 results. If you are...
NasdaqGS:CSX
NasdaqGS:CSXTransportation

The Bull Case For CSX (CSX) Could Change Following Weather-Driven Chicago–Grand Rapids Line Shutdown

A recent flood-related washout near Coloma forced CSX to shut down its rail line between Chicago and Grand Rapids, halting both freight operations and Amtrak’s Pere Marquette passenger service while repairs to the undermined track bed proceed. This disruption highlights how extreme weather can quickly strain rail reliability and raise short-term costs for infrastructure owners like CSX, even on well-used corridors. We’ll now examine how this weather-driven line shutdown, and the repair...
NasdaqGS:FRMI
NasdaqGS:FRMISpecialized REITs

A Look At Fermi (FRMI) Valuation After Major Power Financing And Permit Expansion News

Fermi (FRMI) is back in focus after securing up to US$156.25 million in committed financing through a new senior unsecured promissory note, alongside recent equipment loans and fresh clean air permit applications for large scale power projects. See our latest analysis for Fermi. Despite announcing large financing facilities and expanded clean air permit applications, Fermi’s recent share price return has been weak. The 30 day share price return is 38.33% and the year to date share price...
NYSE:HLF
NYSE:HLFPersonal Products

Herbalife (HLF) Is Down 5.3% After Issuing 2026 Net Sales Growth Guidance And Turnaround Update

Herbalife recently issued Q1 and full-year 2026 net sales growth guidance, projecting reported net sales to increase between 3.0% and 7.0% year over year for Q1 and 1.0% to 6.0% for 2026, prompting analysts to reassess the company’s turnaround prospects. The shift in analyst fair value estimates to US$16.50 highlights how updated guidance and evolving views on Herbalife’s turnaround are reshaping expectations for its business performance. We’ll now examine how Herbalife’s newly issued 2026...
NYSE:GRMN
NYSE:GRMNConsumer Durables

A Look At Garmin (GRMN) Valuation After Natural Cycles Integration Drives Fresh Interest

Garmin’s Natural Cycles integration: what it could mean for the stock Garmin (GRMN) is drawing fresh attention after announcing a product integration with Natural Cycles, the FDA cleared birth control and fertility app, on select smartwatch models across multiple major markets. This partnership brings overnight skin temperature tracking from compatible Garmin devices directly into the Natural Cycles app, expanding Garmin’s women’s health capabilities and potentially strengthening the appeal...
NYSE:AXS
NYSE:AXSInsurance

A Look At AXIS Capital Holdings (AXS) Valuation After Recent Share Price Softness

AXIS Capital Holdings stock context AXIS Capital Holdings (AXS) has drawn investor attention after a period of mixed share performance, with the stock showing a 1 day decline of 0.38% and a past month decline of 1.90%. Over the past 3 months, AXIS Capital Holdings has recorded a 2.09% decline, while the 1 year total return stands at 16.11%, set against a market value of about US$7.5b. See our latest analysis for AXIS Capital Holdings. AXIS Capital Holdings’ recent 1 day and 3 month share...
NYSE:A
NYSE:ALife Sciences

How New Diagnostic Win and Patent Loss Will Impact Agilent Technologies (A) Investors

In recent weeks, Agilent Technologies secured FDA approval for an expanded PD-L1 IHC 22C3 pharmDx cancer companion diagnostic indication and introduced the BioTek Cytation 9 cell imaging multimode reader, while the U.S. Supreme Court let stand rulings invalidating two of its CRISPR-related patents. This combination of a broader clinical diagnostic role alongside a new high-content lab instrument launch, set against a legal setback in gene-editing IP, reshapes how investors may view Agilent’s...
NYSE:DECK
NYSE:DECKLuxury

Assessing Deckers Outdoor (DECK) Valuation After A Mixed Recent Share Price Performance

Assessing Deckers Outdoor after a mixed share price run Deckers Outdoor (DECK) has had a mixed share price run lately, with a 1 day decline, a modest gain over the past week, and negative returns over the month and past 3 months, prompting a closer look at fundamentals. See our latest analysis for Deckers Outdoor. At a share price of $100.26, Deckers Outdoor has seen recent share price pressure, with a 30 day share price return of 3.83% and a year to date share price return of 6.11%. Longer...
ASX:LOT
ASX:LOTOil and Gas

What Lotus Resources (ASX:LOT)'s Fire-Related Production Halt at Kayelekera Means For Shareholders

Lotus Resources recently reported that a fire damaged two newly installed electrical control panels in the drying and packaging area of its Kayelekera uranium mine, forcing a production halt of about three weeks while repairs, testing and recommissioning are completed. Despite this operational setback, the company maintains that Kayelekera remains on track to reach steady-state production in the second quarter of calendar year 2026, highlighting management’s confidence in the broader project...
NasdaqGS:BCRX
NasdaqGS:BCRXBiotechs

A Look At BioCryst Pharmaceuticals (BCRX) Valuation After New R&D Leadership Appointment

BioCryst Pharmaceuticals (BCRX) is in focus after appointing Sandeep M. Menon as Chief Research and Development Officer, a leadership change that directly ties to its rare disease pipeline and longer term R&D priorities. See our latest analysis for BioCryst Pharmaceuticals. At a share price of $9.59, BioCryst has seen a 30 day share price return of 13.09% and year to date share price return of 27.87%, while the 1 year total shareholder return of 48.22% points to building momentum around...